AAAAAA

   
Results: 1-15 |
Results: 15

Authors: MANGEL AW HAHN BA HEATH AT NORTHCUTT AR KONG S DUKES GE MCSORLEY D
Citation: Aw. Mangel et al., ADEQUATE RELIEF AS AN END-POINT IN CLINICAL-TRIALS IN IRRITABLE-BOWEL-SYNDROME, Journal of international medical research, 26(2), 1998, pp. 76-81

Authors: NORTHCUTT AR CAMILLERI M MAYER EA DROSSMAN DA DUKES GE EHSANULLAH RSB HAMM LR HARDING JP HEATH AT JACQUES L WOLFE S KONG S MCSORLEY D MANGEL AW
Citation: Ar. Northcutt et al., ALOSETRON, A 5HT(3)-RECEPTOR ANTAGONIST, IS EFFECTIVE IN THE TREATMENT OF FEMALE IRRITABLE-BOWEL-SYNDROME PATIENTS, Gastroenterology, 114(4), 1998, pp. 3336-3336

Authors: DUKES GE
Citation: Ge. Dukes, ISSUES AND TRENDS IN CLINICAL PHARMACY PRACTICE, RESEARCH, AND EDUCATION - AN INTRODUCTION, Pharmacotherapy, 17(5), 1997, pp. 1062-1062

Authors: JONES KM LIAO E HOHNEKER K TURPIN S HENRY MM SELINGER K HSYU PH BOUCHER RC KNOWLES MR DUKES GE
Citation: Km. Jones et al., PHARMACOKINETICS OF AMILORIDE AFTER INHALATION AND ORAL-ADMINISTRATION IN ADOLESCENTS AND ADULTS WITH CYSTIC-FIBROSIS, Pharmacotherapy, 17(2), 1997, pp. 263-270

Authors: HARDING JP HAMM LR EHSANULLAH RSB HEATH AT SORRELLS SC HAW J DUKES GE WOLFE SG MANGEL AW NORTHCUTT AR
Citation: Jp. Harding et al., USE OF A NOVEL ELECTRONIC DATA-COLLECTION SYSTEM IN MULTICENTER STUDIES OF IRRITABLE-BOWEL-SYNDROME, Alimentary pharmacology & therapeutics, 11(6), 1997, pp. 1073-1076

Authors: ZAROWITZ BJ NAPPI J DUKES GE CARTER BL BOUCHER BA BUSSEY HI HAK LJ HARDIN TC LAKE KD OCONNELL MB WELLS BG ELENBAAS RM KIRK JK MICHAEL KA MARKOWSKY SJ RESTINO MR
Citation: Bj. Zarowitz et al., CRITICAL PATHWAYS - THE TIME IS HERE FOR PHARMACIST INVOLVEMENT, Pharmacotherapy, 16(4), 1996, pp. 723-733

Authors: FIGG WD DUKES GE PRITCHARD JF HERMANN DJ LESESNE HR CARSON SW SONGER SS POWELL R HAK LJ
Citation: Wd. Figg et al., PHARMACOKINETICS OF ONDANSETRON IN PATIENTS WITH HEPATIC INSUFFICIENCY, Journal of clinical pharmacology, 36(3), 1996, pp. 206-215

Authors: KNUPP CA HAK LJ COAKLEY DF FALK RJ WAGNER BE RAASCH RH VANDERHORST CM KAUL S BARBHAIYA RH DUKES GE
Citation: Ca. Knupp et al., DISPOSITION OF DIDANOSINE IN HIV-SEROPOSITIVE PATIENTS WITH NORMAL RENAL-FUNCTION OR CHRONIC-RENAL-FAILURE - INFLUENCE OF HEMODIALYSIS AND CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, Clinical pharmacology and therapeutics, 60(5), 1996, pp. 535-542

Authors: WARNER PE BROUWER KLR HUSSEY EK DUKES GE HEIZER WD DONN KH DAVIS IM POWELL JR
Citation: Pe. Warner et al., SUMATRIPTAN ABSORPTION FROM DIFFERENT REGIONS OF THE HUMAN GASTROINTESTINAL-TRACT, Pharmaceutical research, 12(1), 1995, pp. 138-143

Authors: FIGG WD DUKES GE LESESNE HR CARSON SW SONGER SS PRITCHARD JF HERMANN DJ POWELL JR HAK LJ
Citation: Wd. Figg et al., COMPARISON OF QUANTITATIVE METHODS TO ASSESS HEPATIC-FUNCTION - PUGHSCLASSIFICATION, INDOCYANINE GREEN, ANTIPYRINE, AND DEXTROMETHORPHAN, Pharmacotherapy, 15(6), 1995, pp. 693-700

Authors: JAMERSON BD DUKES GE BROUWER KLR DONN KH MESSENHEIMER JA POWELL JR
Citation: Bd. Jamerson et al., VENOUS IRRITATION RELATED TO INTRAVENOUS ADMINISTRATION OF PHENYTOIN VERSUS FOSPHENYTOIN, Pharmacotherapy, 14(1), 1994, pp. 47-52

Authors: APPLEFELD JJ KASMER RJ HAK LJ DUKES GE WERMELING DP MCCLAIN CJ
Citation: Jj. Applefeld et al., A DOSE-RESPONSE STUDY OF ORALLY-ADMINISTERED TORSEMIDE IN PATIENTS WITH ASCITES DUE TO CIRRHOSIS, Alimentary pharmacology & therapeutics, 8(4), 1994, pp. 397-402

Authors: ZAROWITZ BJ VLASSES PH DUKES GE GAL P MILLER WA PORTER WC RUSH DR SCHNEIDER P TALBERT RL
Citation: Bj. Zarowitz et al., PHARMACOTHERAPY SPECIALTY CERTIFICATION EXAMINATION .4. 1992 RESULTS AND PROCESS MODIFICATIONS, INCLUDING RECERTIFICATION, Pharmacotherapy, 13(3), 1993, pp. 262-266

Authors: FIGG WD GRAHAM CL HAK LJ DUKES GE
Citation: Wd. Figg et al., ONDANSETRON - A NOVEL ANTIEMETIC AGENT, Southern medical journal, 86(5), 1993, pp. 497-502

Authors: LIAO E DUKES GE FOX JL
Citation: E. Liao et al., IN-LINE FILTRATION OF ONDANSETRON HYDROCHLORIDE DURING SIMULATED IV ADMINISTRATION, American journal of hospital pharmacy, 50(5), 1993, pp. 906
Risultati: 1-15 |